The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Kane Biotech Inc.

  • KNE
  • TSX Venture
  • Consumer Products
  • Latest 0.045
  • Currency C$
  • Change 0.0000
  • Percent Change 0.00 %
  • Volume 100,000
  • Thu Oct 23, 2014 12:45 PM EDT TSX Venture data delayed 15 minutes.
  • Open 0.045
  • Previous Close 0.045
  • High 0.045
  • Low 0.045
  • Bidx270,000 0.04
  • Askx187,000 0.05
  • 52-week High02/05 0.125
  • 52-week Low09/18 0.04
  • Beta 0.789
  • Market Cap 2.73M
  • EPS -0.02
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $20,188
  • Earnings $-1,221,149
  • Return on Equity n/a

Cash Flow

  • Cash Flow $-903,276
  • Cash $1,319,386
  • Current Ratio 15.41

12 months ended Dec 31, 2011.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $2,470,808
  • Liabilities $92,725
  • Liabilities-to-Equity Ratio 0.04

Price Ratios

  • Price to Sales n/a
  • Price to Book 1.15
  • Price to Cash Flow -2.81

Event Calendar

Event Last   Next  
Earnings n/a n/a n/a n/a
Surprises n/a n/a n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Oct 23, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

KANE BIOTECH INC. is a biomedicalcompany developing products that prevent and disperse biofilms for the healthcare industry.

Related Securities
Symbol Type Latest % Chg

Officers

  • Gord Froehlich President & C.E.O.
  • Eric Johnstone C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: n/a
  • Incorporation: Canada,
    Jan 29, 2003
  • Top 1000 Ranking: Profit: 0
    Revenue: 0
    Assets: 0

Head Office

5 - 1250 Waverley Street
Winnipeg, MB
R3T 6C6

Phone: (204)-453-1301
Fax: (204)-4531314

info@kanebiotech.com
www.kanebiotech.com

Ideas & Discussion

Live Discussion of KNE on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.